Hepatocellular carcinoma in the era of immunotherapy
- PMID: 29150141
- DOI: 10.1016/j.currproblcancer.2017.10.007
Hepatocellular carcinoma in the era of immunotherapy
Abstract
Hepatocellular carcinoma is a common malignancy which usually emerges on a background of chronic liver disease. Unfortunately, with contemporary management, patients with advanced hepatocellular carcinoma have few treatment options, and prognosis is poor. The emergence of immunotherapy has afforded new therapeutic opportunities. This article reviews the clinical evidence for immunotherapy in advanced hepatocellular carcinoma and presents ideas for future drug development.
Keywords: Drug development; Hepatocellular carcinoma; Immunotherapy; Management; Review.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
